2GW9 image
Deposition Date 2006-05-04
Release Date 2006-07-25
Last Version Date 2024-11-20
Entry Detail
PDB ID:
2GW9
Keywords:
Title:
High-resolution solution structure of the mouse defensin Cryptdin4
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
50
Conformers Submitted:
20
Selection Criteria:
structures with the least restraint violations,structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Defensin-related cryptdin 4
Gene (Uniprot):Defa4
Chain IDs:A
Chain Length:32
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Structural and functional characterization of the conserved salt bridge in mammalian paneth cell alpha-defensins: solution structures of mouse CRYPTDIN-4 and (E15D)-CRYPTDIN-4.
J.Biol.Chem. 281 28068 28078 (2006)
PMID: 16857681 DOI: 10.1074/jbc.M604992200

Abstact

alpha-Defensins are mediators of mammalian innate immunity, and knowledge of their structure-function relationships is essential for understanding their mechanisms of action. We report here the NMR solution structures of the mouse Paneth cell alpha-defensin cryptdin-4 (Crp4) and a mutant (E15D)-Crp4 peptide, in which a conserved Glu(15) residue was replaced by Asp. Structural analysis of the two peptides confirms the involvement of this Glu in a conserved salt bridge that is removed in the mutant because of the shortened side chain. Despite disruption of this structural feature, the peptide variant retains a well defined native fold because of a rearrangement of side chains, which result in compensating favorable interactions. Furthermore, salt bridge-deficient Crp4 mutants were tested for bactericidal effects and resistance to proteolytic degradation, and all of the variants had similar bactericidal activities and stability to proteolysis. These findings support the conclusion that the function of the conserved salt bridge in Crp4 is not linked to bactericidal activity or proteolytic stability of the mature peptide.

Legend

Protein

Chemical

Disease

Primary Citation of related structures